PURPOSE: Death rates of patients with epilepsy are two to three times higher than expected. The aim of our study was to further delineate the causes and the patterns of premature death in patients with epilepsy. METHODS: We included all patients who were prospectively enrolled between 1970 and 1999 in our epilepsy outpatient clinical database. Patients were followed until death or December 31, 2003. Standardized mortality ratios (SMRs) were calculated using reference rates from the same region. KEY FINDINGS: After 48,595 person years of follow-up, 648 of 3,334 patients had died, resulting in an overall SMR of 2.2 (95% confidence interval [CI] 2.0-2.4). The highest SMRs were for patients aged 26-45 years (6.8, 95% CI 3.8-11.2) and with symptomatic epilepsies (3.1, 95% CI 2.3-4.9); those for cryptogenic causes (2.2, 95% CI 1.6-3.1) were also elevated, whereas those for idiopathic causes were not increased (2.7, 95% CI 0.7-7.0) after 2 years of follow-up. SMRs for patients with persistent seizures (3.3, 95% CI 2.6-4.4) were higher than those for seizure-free patients (1.4, 95% CI 0.8-2.3). The highest cause-specific SMRs were for epilepsy (91.6, 95% CI 66.3-123.4), brain tumors (22.7, 95% CI 15.7-31.8), and external causes (2.4, 95% CI 1.8-3.3) at end of study period. SIGNIFICANCE: Epilepsy patients have a higher-than-expected risk of death throughout life and especially during the first 2 years following diagnosis. Standardized mortality rates were especially high in younger patients and in patients with symptomatic epilepsies. Persistent seizures are strongly related to excess mortality. Wiley Periodicals, Inc.
PURPOSE:Death rates of patients with epilepsy are two to three times higher than expected. The aim of our study was to further delineate the causes and the patterns of premature death in patients with epilepsy. METHODS: We included all patients who were prospectively enrolled between 1970 and 1999 in our epilepsyoutpatient clinical database. Patients were followed until death or December 31, 2003. Standardized mortality ratios (SMRs) were calculated using reference rates from the same region. KEY FINDINGS: After 48,595 person years of follow-up, 648 of 3,334 patients had died, resulting in an overall SMR of 2.2 (95% confidence interval [CI] 2.0-2.4). The highest SMRs were for patients aged 26-45 years (6.8, 95% CI 3.8-11.2) and with symptomatic epilepsies (3.1, 95% CI 2.3-4.9); those for cryptogenic causes (2.2, 95% CI 1.6-3.1) were also elevated, whereas those for idiopathic causes were not increased (2.7, 95% CI 0.7-7.0) after 2 years of follow-up. SMRs for patients with persistent seizures (3.3, 95% CI 2.6-4.4) were higher than those for seizure-freepatients (1.4, 95% CI 0.8-2.3). The highest cause-specific SMRs were for epilepsy (91.6, 95% CI 66.3-123.4), brain tumors (22.7, 95% CI 15.7-31.8), and external causes (2.4, 95% CI 1.8-3.3) at end of study period. SIGNIFICANCE: Epilepsypatients have a higher-than-expected risk of death throughout life and especially during the first 2 years following diagnosis. Standardized mortality rates were especially high in younger patients and in patients with symptomatic epilepsies. Persistent seizures are strongly related to excess mortality. Wiley Periodicals, Inc.
Authors: David J Thurman; Giancarlo Logroscino; Ettore Beghi; W Allen Hauser; Dale C Hesdorffer; Charles R Newton; Fulvio Alexandre Scorza; Josemir W Sander; Torbjörn Tomson Journal: Epilepsia Date: 2016-11-26 Impact factor: 5.864
Authors: Kitti Kaiboriboon; Nicholas K Schiltz; Paul M Bakaki; Samden D Lhatoo; Siran M Koroukian Journal: Epilepsia Date: 2014-09-19 Impact factor: 5.864
Authors: Olli Nevalainen; Mikko Simola; Hanna Ansakorpi; Jani Raitanen; Miia Artama; Jouko Isojärvi; Anssi Auvinen Journal: Eur J Epidemiol Date: 2015-10-31 Impact factor: 8.082
Authors: Hayley C Gorton; Roger T Webb; Matthew J Carr; Marcos DelPozo-Banos; Ann John; Darren M Ashcroft Journal: JAMA Neurol Date: 2018-08-01 Impact factor: 18.302
Authors: Bora Inceoglu; Dorota Zolkowska; Hyun Ju Yoo; Karen M Wagner; Jun Yang; Edward Hackett; Sung Hee Hwang; Kin Sing Stephen Lee; Michael A Rogawski; Christophe Morisseau; Bruce D Hammock Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240